Matthew D. Hellmann, MD | Authors

Articles

Nivolumab With Ipilimumab for Small Cell Lung Cancer

July 06, 2017

Matthew D. Hellmann, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the CheckMate-032 study, which explored nivolumab (Opdivo) with or without ipilimumab (Yervoy) for patients with small cell lung cancer (SCLC).